These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 38046334)
61. PpIX/IR-820 Dual-Modal Therapeutic Agents for Enhanced PDT/PTT Synergistic Therapy in Cervical Cancer. Yan T; Alimu G; Zhu L; Fan H; Zhang L; Du Z; Ma R; Chen S; Alifu N; Zhang X ACS Omega; 2022 Dec; 7(49):44643-44656. PubMed ID: 36530282 [TBL] [Abstract][Full Text] [Related]
62. Targeting carbonic anhydrase IX depletes breast cancer stem cells within the hypoxic niche. Lock FE; McDonald PC; Lou Y; Serrano I; Chafe SC; Ostlund C; Aparicio S; Winum JY; Supuran CT; Dedhar S Oncogene; 2013 Oct; 32(44):5210-9. PubMed ID: 23208505 [TBL] [Abstract][Full Text] [Related]
63. Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer. Ong CHC; Lee DY; Lee B; Li H; Lim JCT; Lim JX; Yeong JPS; Lau HY; Thike AA; Tan PH; Iqbal J Breast Cancer Res; 2022 Jun; 24(1):38. PubMed ID: 35659359 [TBL] [Abstract][Full Text] [Related]
64. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs. Dubois L; Peeters SG; van Kuijk SJ; Yaromina A; Lieuwes NG; Saraya R; Biemans R; Rami M; Parvathaneni NK; Vullo D; Vooijs M; Supuran CT; Winum JY; Lambin P Radiother Oncol; 2013 Sep; 108(3):523-8. PubMed ID: 23849171 [TBL] [Abstract][Full Text] [Related]
65. Antibody inhibiting enzymatic activity of tumour-associated carbonic anhydrase isoform IX. Murri-Plesko MT; Hulikova A; Oosterwijk E; Scott AM; Zortea A; Harris AL; Ritter G; Old L; Bauer S; Swietach P; Renner C Eur J Pharmacol; 2011 Apr; 657(1-3):173-83. PubMed ID: 21315712 [TBL] [Abstract][Full Text] [Related]
66. Encapsulation of anti-carbonic anhydrase IX antibody in hydrogel microspheres for tumor targeting. Takacova M; Hlouskova G; Zatovicova M; Benej M; Sedlakova O; Kopacek J; Pastorek J; Lacik I; Pastorekova S J Enzyme Inhib Med Chem; 2016; 31(sup1):110-118. PubMed ID: 27140748 [TBL] [Abstract][Full Text] [Related]
67. A Targeted and pH-Responsive Nano-Graphene Oxide Nanoparticle Loaded with Doxorubicin for Synergetic Chemo-Photothermal Therapy of Oral Squamous Cell Carcinoma. Li R; Liu C; Wan C; Liu T; Zhang R; Du J; Wang X; Jiao X; Gao R; Li B Int J Nanomedicine; 2023; 18():3309-3324. PubMed ID: 37351329 [TBL] [Abstract][Full Text] [Related]
68. Self-assembled tumor-targeting hyaluronic acid nanoparticles for photothermal ablation in orthotopic bladder cancer. Lin T; Yuan A; Zhao X; Lian H; Zhuang J; Chen W; Zhang Q; Liu G; Zhang S; Chen W; Cao W; Zhang C; Wu J; Hu Y; Guo H Acta Biomater; 2017 Apr; 53():427-438. PubMed ID: 28213097 [TBL] [Abstract][Full Text] [Related]
69. Cetuximab-modified CuS nanoparticles integrating near-infrared-II-responsive photothermal therapy and anti-vessel treatment. Li B; Jiang Z; Xie D; Wang Y; Lao X Int J Nanomedicine; 2018; 13():7289-7302. PubMed ID: 30510418 [TBL] [Abstract][Full Text] [Related]
70. A sequential targeting nanoplatform for anaplastic thyroid carcinoma theranostics. Wang Q; Sui G; Wu X; Teng D; Zhu L; Guan S; Ran H; Wang Z; Wang H Acta Biomater; 2020 Jan; 102():367-383. PubMed ID: 31778831 [TBL] [Abstract][Full Text] [Related]
71. Carbonic anhydrase IX inhibition affects viability of cancer cells adapted to extracellular acidosis. Andreucci E; Peppicelli S; Carta F; Brisotto G; Biscontin E; Ruzzolini J; Bianchini F; Biagioni A; Supuran CT; Calorini L J Mol Med (Berl); 2017 Dec; 95(12):1341-1353. PubMed ID: 28929255 [TBL] [Abstract][Full Text] [Related]
72. Copper-Free 'Click' Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia. Tatiparti K; Sau S; Gawde KA; Iyer AK Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534020 [TBL] [Abstract][Full Text] [Related]
73. Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. Leibovich BC; Sheinin Y; Lohse CM; Thompson RH; Cheville JC; Zavada J; Kwon ED J Clin Oncol; 2007 Oct; 25(30):4757-64. PubMed ID: 17947723 [TBL] [Abstract][Full Text] [Related]
74. Antibody-pHPMA functionalised fluorescent silica nanoparticles for colorectal carcinoma targeting. Lizoňová D; Majerská M; Král V; Pechar M; Pola R; Kovář M; Štěpánek F RSC Adv; 2018 Jun; 8(39):21679-21689. PubMed ID: 35541757 [TBL] [Abstract][Full Text] [Related]
75. Dual targeting smart drug delivery system for multimodal synergistic combination cancer therapy with reduced cardiotoxicity. Shubhra QTH; Guo K; Liu Y; Razzak M; Serajum Manir M; Moshiul Alam AKM Acta Biomater; 2021 Sep; 131():493-507. PubMed ID: 34139367 [TBL] [Abstract][Full Text] [Related]
76. Tumor-targeting CuS nanoparticles for multimodal imaging and guided photothermal therapy of lymph node metastasis. Shi H; Yan R; Wu L; Sun Y; Liu S; Zhou Z; He J; Ye D Acta Biomater; 2018 May; 72():256-265. PubMed ID: 29588255 [TBL] [Abstract][Full Text] [Related]
77. Single wavelength light-mediated, synergistic bimodal cancer photoablation and amplified photothermal performance by graphene/gold nanostar/photosensitizer theranostics. Wu C; Li D; Wang L; Guan X; Tian Y; Yang H; Li S; Liu Y Acta Biomater; 2017 Apr; 53():631-642. PubMed ID: 28161572 [TBL] [Abstract][Full Text] [Related]
78. Quantitative Imaging of Hypoxic CAIX-Positive Tumor Areas with Low Immune Cell Infiltration in Syngeneic Mouse Tumor Models. Boreel DF; Span PN; Kip A; Boswinkel M; Peters JPW; Adema GJ; Bussink J; Heskamp S Mol Pharm; 2023 Apr; 20(4):2245-2255. PubMed ID: 36882391 [TBL] [Abstract][Full Text] [Related]
79. In Vivo Imaging-Guided Photothermal/Photoacoustic Synergistic Therapy with Bioorthogonal Metabolic Glycoengineering-Activated Tumor Targeting Nanoparticles. Du L; Qin H; Ma T; Zhang T; Xing D ACS Nano; 2017 Sep; 11(9):8930-8943. PubMed ID: 28892360 [TBL] [Abstract][Full Text] [Related]
80. Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9. Petrul HM; Schatz CA; Kopitz CC; Adnane L; McCabe TJ; Trail P; Ha S; Chang YS; Voznesensky A; Ranges G; Tamburini PP Mol Cancer Ther; 2012 Feb; 11(2):340-9. PubMed ID: 22147747 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]